These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7325887)

  • 21. Murine cutaneous leishmaniasis: comparative study on the capacity of macrophages from "healer" and "non-healer" mouse strains to control L. tropica replication.
    Streck H; Bogdan C; Tingle A; Röllinghoff M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Mar; 263(4):594-604. PubMed ID: 3474848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The glycoconjugate derived from a Leishmania major receptor for macrophages is a suppressogenic, disease-promoting antigen in murine cutaneous leishmaniasis.
    Mitchell GF; Handman E
    Parasite Immunol; 1986 May; 8(3):255-63. PubMed ID: 2425330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities.
    Nacy CA; Fortier AH; Pappas MG; Henry RR
    Cell Immunol; 1983 Apr; 77(2):298-307. PubMed ID: 6850844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice.
    Heinzel FP; Sadick MD; Locksley RM
    Exp Parasitol; 1988 Apr; 65(2):258-68. PubMed ID: 3127233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.
    Rostamian M; Bahrami F; Niknam HM
    PLoS One; 2018; 13(9):e0204491. PubMed ID: 30248142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
    Lelchuk R; Graveley R; Liew FY
    Cell Immunol; 1988 Jan; 111(1):66-76. PubMed ID: 3257416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis.
    Handman E; Mitchell GF
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5910-4. PubMed ID: 3862105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous leishmaniasis infection in Balb/c mice using a Leishmania tropica strain isolated from Turkey.
    Girginkardeşler N; Balcioğlu IC; Yereli K; Ozbilgin A; Ozbel Y
    J Parasitol; 2001 Oct; 87(5):1177-8. PubMed ID: 11695390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.
    Nasseri M; Modabber FZ
    Infect Immun; 1979 Nov; 26(2):611-4. PubMed ID: 546790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.
    Liew FY; Millott S; Lelchuk R; Cobbold S; Waldmann H
    Clin Exp Immunol; 1989 Mar; 75(3):438-43. PubMed ID: 2784747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An immunologic method of producing antigens for the treatment and prevention of leishmaniasis].
    Vouldoukis I; Monjour L
    C R Acad Sci III; 1989; 308(5):129-34. PubMed ID: 2493318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG; Liew FY
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro assessment of anti-Leishmania immunity of man acquired with a vaccine.
    Vouldoukis I; Ogunkolade BW; Frommel D; Alier N; Monjour L
    Experientia; 1988 Jan; 44(1):56-7. PubMed ID: 3350121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    Liew FY; Hale C; Howard JG
    J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man.
    Peters W; Bryceson A; Evans DA; Neal RA; Kaye P; Blackwell J; Killick-Kendrick R; Liew FY
    Trans R Soc Trop Med Hyg; 1990; 84(5):681-9. PubMed ID: 2126153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.